Cellanome

Cellanome is a privately held biotechnology company based in East Palo Alto, California. The company employs a team of 5 individuals, generating $50 million in annual revenue. Cellanome develops an automated platform designed to provide researchers with a deeper understanding of individual cell behaviors, interactions, and functions. Their platform facilitates the analysis of cells in response to various stimuli and parameters, enabling researchers to explore a broader range of cell types and functions at a large scale. The platform's capabilities include iterative live cell phenotypic and functional assays, allowing researchers to observe individual cellular responses to specific perturbations. It also supports combinatorial assays without the need to switch platforms or use additional samples. The platform is compatible with a variety of cell types, including larger and more challenging cell types, and allows for the observation of cell-to-cell interactions over time. For further information about Cellanome and their platform, please visit their website at cellanome.com.